FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmacology and medicine and represents pharmaceutical composition, which contains conjugate or its pharmaceutically acceptable salt, where said conjugate includes: polypeptide, which contains amino acidsequence, at least, by 80% identical to sequence Angiopep-2 (SEQ ID NO.:97); and at least, one molecule of taxol, conjugated with said polypeptide; and Solutol® HS-15.
EFFECT: invention insures increasing action of anticancer medications.
23 cl, 14 ex, 7 tbl, 28 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| APROTININ POLYPEPTIDES FOR TRANSPORT OF COMPOUND THROUGH BLOOD-BRAIN BARRIER | 2010 |
|
RU2611193C2 |
| POLYPEPTIDE CAPABLE OF OVERCOMING HEMATOENCEPHALIC BARRIER, AND CONJUGATE THEREOF | 2005 |
|
RU2408605C2 |
| ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY | 2009 |
|
RU2531591C2 |
| COMPOSITION BASED ON HYDROPHOBIC AGENTS AND METHOD FOR PREPARING IT (VERSIONS) | 2009 |
|
RU2518240C2 |
| ANTI-SEZ6 ANTIBODIES AND METHODS FOR USING THEM | 2013 |
|
RU2691698C2 |
| ANTI-PTK7 ANTIBODY-DRUG CONJUGATES | 2015 |
|
RU2708075C2 |
| ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2009 |
|
RU2553566C2 |
| COMBINED THERAPY BASED ON AFUCOSYLATED CD20 ANTIBODY IN COMBINATION WITH CD22 ANTIBODY CONJUGATE - DRUG PREPARATION | 2014 |
|
RU2700092C2 |
| METHOD FOR CANCER DETECTION | 2013 |
|
RU2646466C2 |
| ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2008 |
|
RU2511410C2 |
